| Literature DB >> 24814193 |
Heon Yung Gee1, Shazia Ashraf1, Xiaoyang Wan2, Virginia Vega-Warner2, Julian Esteve-Rudd3, Svjetlana Lovric1, Humphrey Fang1, Toby W Hurd4, Carolin E Sadowski1, Susan J Allen2, Edgar A Otto2, Emine Korkmaz5, Joseph Washburn6, Shawn Levy7, David S Williams3, Sevcan A Bakkaloglu8, Anna Zolotnitskaya9, Fatih Ozaltin10, Weibin Zhou2, Friedhelm Hildebrandt11.
Abstract
Nephrotic syndrome (NS) is a genetically heterogeneous group of diseases that are divided into steroid-sensitive NS (SSNS) and steroid-resistant NS (SRNS). SRNS inevitably leads to end-stage kidney disease, and no curative treatment is available. To date, mutations in more than 24 genes have been described in Mendelian forms of SRNS; however, no Mendelian form of SSNS has been described. To identify a genetic form of SSNS, we performed homozygosity mapping, whole-exome sequencing, and multiplex PCR followed by next-generation sequencing. We thereby detected biallelic mutations in EMP2 (epithelial membrane protein 2) in four individuals from three unrelated families affected by SRNS or SSNS. We showed that EMP2 exclusively localized to glomeruli in the kidney. Knockdown of emp2 in zebrafish resulted in pericardial effusion, supporting the pathogenic role of mutated EMP2 in human NS. At the cellular level, we showed that knockdown of EMP2 in podocytes and endothelial cells resulted in an increased amount of CAVEOLIN-1 and decreased cell proliferation. Our data therefore identify EMP2 mutations as causing a recessive Mendelian form of SSNS.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24814193 PMCID: PMC4121470 DOI: 10.1016/j.ajhg.2014.04.010
Source DB: PubMed Journal: Am J Hum Genet ISSN: 0002-9297 Impact factor: 11.025